Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
May 07 04:00PM ET
248.76
Dollar change
+1.36
Percentage change
0.55
%
IndexS&P 500 P/E42.17 EPS (ttm)5.90 Insider Own8.82% Shs Outstand739.20M Perf Week0.87%
Market Cap184.25B Forward P/E28.72 EPS next Y8.66 Insider Trans-0.16% Shs Float675.37M Perf Month1.85%
Income4.40B PEG5.61 EPS next Q1.59 Inst Own81.75% Short Float0.92% Perf Quarter0.23%
Sales26.23B P/S7.02 EPS this Y0.26% Inst Trans-0.21% Short Ratio2.40 Perf Half Y25.72%
Book/sh72.16 P/B3.45 EPS next Y13.99% ROA5.28% Short Interest6.20M Perf Year15.76%
Cash/sh9.49 P/C26.21 EPS next 5Y7.52% ROE8.47% 52W Range182.09 - 259.00 Perf YTD7.53%
Dividend Est.0.96 (0.39%) P/FCF33.16 EPS past 5Y11.31% ROI6.30% 52W High-3.95% Beta0.85
Dividend TTM1.05 (0.42%) Quick Ratio1.51 Sales past 5Y8.35% Gross Margin58.35% 52W Low36.61% ATR (14)4.79
Dividend Ex-DateMar 27, 2024 Current Ratio1.85 EPS Y/Y TTM-36.66% Oper. Margin21.32% RSI (14)55.04 Volatility1.59% 1.77%
Employees63000 Debt/Eq0.36 Sales Y/Y TTM-15.25% Profit Margin16.78% Recom1.65 Target Price274.37
Option/ShortYes / Yes LT Debt/Eq0.31 EPS Q/Q-25.02% Payout16.45% Rel Volume0.63 Prev Close247.40
Sales Surprise3.09% EPS Surprise11.84% Sales Q/Q-19.13% EarningsApr 23 BMO Avg Volume2.58M Price248.76
SMA201.83% SMA500.13% SMA2008.27% Trades Volume1,632,113 Change0.55%
Date Action Analyst Rating Change Price Target Change
Apr-17-24Upgrade HSBC Securities Hold → Buy $280
Jan-24-24Downgrade Barclays Overweight → Equal Weight $240
Dec-18-23Initiated HSBC Securities Hold
Dec-13-23Resumed Wolfe Research Peer Perform
Dec-07-23Downgrade Goldman Buy → Neutral $215 → $205
Jul-19-23Initiated Raymond James Outperform $270
May-01-23Initiated SVB Securities Outperform $300
Apr-26-23Downgrade BofA Securities Buy → Neutral $310 → $250
Apr-18-23Upgrade Wells Fargo Equal Weight → Overweight $275 → $285
Jan-05-23Downgrade Credit Suisse Outperform → Neutral $315 → $300
Today 04:45PM
04:15PM
May-06-24 02:50PM
May-05-24 08:19AM
May-03-24 09:06AM
08:00AM Loading…
May-01-24 08:00AM
Apr-26-24 03:09PM
Apr-25-24 07:00PM
Apr-24-24 09:52AM
03:01AM
01:02AM
Apr-23-24 10:17PM
04:41PM
12:21PM
12:07PM
11:39AM Loading…
11:39AM
11:33AM
11:29AM
10:53AM
10:44AM
09:30AM
07:31AM
07:10AM
06:59AM
06:55AM
06:26AM
06:07AM
06:00AM
05:37AM
Apr-19-24 09:52AM
04:27PM Loading…
Apr-18-24 04:27PM
12:10PM
10:58AM
09:15AM
Apr-17-24 08:00AM
Apr-13-24 12:16PM
Apr-12-24 12:30PM
Apr-11-24 04:30PM
12:19PM
Apr-05-24 06:00PM
Apr-04-24 09:00AM
08:00AM
Apr-02-24 06:15PM
Mar-28-24 03:41AM
Mar-27-24 06:00PM
09:30AM
08:00AM
Mar-26-24 06:15PM
Mar-21-24 04:15PM
10:25AM
09:00AM
Mar-20-24 06:00PM
08:00AM
Mar-18-24 06:15PM
Mar-13-24 10:23AM
08:05AM
Mar-12-24 06:00PM
Mar-11-24 06:15PM
Mar-06-24 06:00AM
Mar-05-24 06:00PM
Mar-04-24 09:06AM
Mar-02-24 10:42AM
Mar-01-24 09:00AM
Feb-29-24 11:30AM
Feb-28-24 06:00PM
Feb-27-24 04:15PM
Feb-25-24 02:38PM
Feb-22-24 09:01PM
04:15PM
Feb-21-24 04:15PM
Feb-17-24 01:28PM
Feb-12-24 03:03PM
Feb-09-24 01:40AM
Feb-05-24 07:30AM
Feb-01-24 11:08AM
Jan-30-24 11:14PM
01:26PM
11:44AM
11:08AM
09:30AM
07:10AM
06:34AM
06:17AM
06:00AM
Jan-29-24 12:56PM
08:36AM
07:30AM
Jan-26-24 08:10AM
Jan-25-24 09:15AM
Jan-23-24 10:00AM
Jan-22-24 06:00PM
Jan-19-24 04:27AM
Jan-17-24 12:10PM
Jan-16-24 06:15PM
Jan-10-24 06:00PM
Jan-09-24 06:15PM
09:19AM
07:30AM
Jan-08-24 04:15PM
Jan-03-24 06:00PM
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SPOON ALAN GDirectorMay 02 '24Option Exercise52.563,289172,870116,910May 03 05:03 PM
SPOON ALAN GDirectorMay 02 '24Sale243.58708172,455116,202May 03 05:03 PM
Weidemanis JoakimExecutive Vice PresidentApr 25 '24Option Exercise58.4822,4331,311,882112,845Apr 26 05:00 PM
Weidemanis JoakimExecutive Vice PresidentApr 25 '24Sale250.4622,4335,618,56990,412Apr 26 05:00 PM
Blair RainerPresident & CEOApr 24 '24Option Exercise59.9138,1702,286,870154,165Apr 25 05:00 PM
Blair RainerPresident & CEOApr 24 '24Sale249.2247,17511,756,725115,995Apr 25 05:00 PM
Ellis Brian WSenior Vice President - GCApr 24 '24Sale250.014,0001,000,04029,830Apr 25 05:00 PM
Raskas DanielSVP - Corporate DevelopmentFeb 26 '24Option Exercise58.4823,7571,389,30961,859Feb 27 05:01 PM
Raskas DanielSVP - Corporate DevelopmentFeb 26 '24Sale252.0023,7575,986,76438,102Feb 27 05:01 PM
LOHR WALTER GDirectorFeb 15 '24Option Exercise52.563,289172,87017,418Feb 16 05:01 PM
LOHR WALTER GDirectorFeb 15 '24Sale251.153,289826,03214,129Feb 16 05:01 PM
Couchara GeorgeannSVP, Human ResourcesFeb 13 '24Option Exercise70.712,622185,4146,022Feb 14 05:00 PM
Couchara GeorgeannSVP, Human ResourcesFeb 13 '24Sale242.672,622636,2904,244Feb 14 05:00 PM
List TeriDirectorFeb 06 '24Option Exercise52.563,289172,87023,015Feb 08 05:00 PM
List TeriDirectorFeb 06 '24Sale248.323,289816,72419,726Feb 08 05:00 PM
Gutierrez-Ramos Jose-CarlosSVP, Chief Science OfficerAug 21 '23Sale250.54590147,8196,939Aug 22 05:00 PM
Raskas DanielSVP - Corporate DevelopmentJul 28 '23Option Exercise56.7011,213635,77749,501Aug 01 05:03 PM
Zerhouni Elias A.DirectorJul 28 '23Option Exercise50.803,490177,29230,523Aug 01 05:02 PM
SCHWIETERS JOHN TDirectorJul 28 '23Option Exercise50.803,490177,29222,583Aug 01 05:02 PM
FILLER LINDADirectorJul 28 '23Option Exercise59.172,922172,89541,074Aug 01 05:00 PM
Raskas DanielSVP - Corporate DevelopmentJul 28 '23Sale260.6511,2132,922,65238,288Aug 01 05:03 PM
FILLER LINDADirectorJul 28 '23Sale260.2510,1902,651,97838,152Aug 01 05:00 PM
Weidemanis JoakimExecutive Vice PresidentJul 26 '23Option Exercise56.7022,4391,272,291111,128Jul 27 05:01 PM
List TeriDirectorJul 26 '23Option Exercise50.803,490177,29220,984Jul 27 05:00 PM
Weidemanis JoakimExecutive Vice PresidentJul 26 '23Sale263.4222,4395,910,83288,689Jul 27 05:01 PM
List TeriDirectorJul 26 '23Sale263.303,490918,91717,494Jul 27 05:00 PM
Raskas DanielSVP - Corporate DevelopmentMay 31 '23Option Exercise57.9019,8471,149,14158,520Jun 01 05:00 PM
Raskas DanielSVP - Corporate DevelopmentMay 31 '23Sale228.5019,8474,535,04038,673Jun 01 05:00 PM
Last Close
May 07 04:00PM ET
77.04
Dollar change
+0.06
Percentage change
0.08
%
FTV Fortive Corp daily Stock Chart
IndexS&P 500 P/E30.44 EPS (ttm)2.53 Insider Own0.41% Shs Outstand350.70M Perf Week2.35%
Market Cap27.12B Forward P/E18.48 EPS next Y4.17 Insider Trans-16.36% Shs Float350.59M Perf Month-8.53%
Income899.60M PEG3.11 EPS next Q0.92 Inst Own95.40% Short Float0.92% Perf Quarter-5.53%
Sales6.13B P/S4.42 EPS this Y11.00% Inst Trans-8.27% Short Ratio1.96 Perf Half Y16.82%
Book/sh29.76 P/B2.59 EPS next Y9.52% ROA5.40% Short Interest3.23M Perf Year19.04%
Cash/sh2.00 P/C38.49 EPS next 5Y9.80% ROE8.84% 52W Range63.05 - 87.10 Perf YTD4.63%
Dividend Est.0.31 (0.41%) P/FCF20.45 EPS past 5Y-21.58% ROI6.16% 52W High-11.55% Beta1.14
Dividend TTM0.30 (0.39%) Quick Ratio1.14 Sales past 5Y0.13% Gross Margin59.55% 52W Low22.19% ATR (14)1.44
Dividend Ex-DateMay 31, 2024 Current Ratio1.47 EPS Y/Y TTM18.77% Oper. Margin18.48% RSI (14)37.45 Volatility1.16% 1.80%
Employees18000 Debt/Eq0.39 Sales Y/Y TTM3.71% Profit Margin14.68% Recom2.05 Target Price88.74
Option/ShortYes / Yes LT Debt/Eq0.39 EPS Q/Q19.63% Payout11.91% Rel Volume0.91 Prev Close76.98
Sales Surprise-0.21% EPS Surprise4.09% Sales Q/Q4.37% EarningsApr 24 BMO Avg Volume1.65M Price77.04
SMA20-2.60% SMA50-6.92% SMA2001.00% Trades Volume1,499,994 Change0.08%
Date Action Analyst Rating Change Price Target Change
Apr-17-24Downgrade JP Morgan Overweight → Neutral $95 → $90
Mar-14-24Initiated Truist Buy $99
Jan-02-24Downgrade Vertical Research Buy → Hold
Oct-26-23Downgrade BofA Securities Buy → Neutral $70
Oct-05-23Initiated Exane BNP Paribas Outperform $91
Aug-07-23Initiated Seaport Research Partners Buy $92
Mar-27-23Upgrade Vertical Research Hold → Buy $74
Oct-12-22Upgrade Morgan Stanley Equal-Weight → Overweight $68 → $73
Mar-17-22Upgrade Argus Hold → Buy $68
Mar-14-22Upgrade Barclays Equal Weight → Overweight $75
May-06-24 02:50PM
May-01-24 04:15PM
12:00PM
Apr-26-24 08:52AM
Apr-25-24 01:01PM
01:04AM Loading…
01:04AM
Apr-24-24 06:38PM
11:52AM
09:30AM
08:51AM
08:40AM
08:10AM
07:39AM
07:30AM
Apr-19-24 09:15AM
09:15AM Loading…
09:15AM
Apr-18-24 09:35AM
Apr-17-24 10:01AM
Apr-04-24 04:15PM
Mar-28-24 04:15PM
03:41AM
Mar-20-24 11:40AM
Mar-19-24 07:00AM
Mar-14-24 09:40AM
Mar-13-24 10:53AM
Mar-12-24 04:15PM
Mar-06-24 04:15PM
Mar-04-24 09:06AM
Mar-01-24 11:30AM
Feb-29-24 09:40AM
12:04AM Loading…
Feb-28-24 12:04AM
Feb-09-24 04:15PM
04:15PM
Feb-08-24 05:27PM
Feb-03-24 12:01PM
Feb-02-24 09:55AM
Feb-01-24 06:54PM
11:17AM
07:22AM
03:20AM
Jan-31-24 06:14PM
09:30AM
08:40AM
07:50AM
07:30AM
Jan-26-24 09:15AM
Jan-24-24 10:00AM
Jan-23-24 04:30PM
04:30PM
Jan-16-24 11:00AM
Jan-04-24 09:03AM
Jan-03-24 07:02AM
Dec-21-23 04:15PM
Dec-05-23 08:00AM
Nov-24-23 11:31AM
Nov-02-23 04:15PM
Oct-31-23 04:15PM
Oct-27-23 02:29PM
Oct-26-23 11:09AM
09:56AM
08:44AM
05:01AM
Oct-25-23 10:17AM
09:48AM
07:51AM
07:30AM
Oct-23-23 06:53AM
06:51AM
06:00AM
Oct-19-23 09:00AM
Oct-18-23 10:01AM
Oct-03-23 02:37PM
Sep-29-23 05:30PM
Sep-19-23 10:30AM
Sep-12-23 11:00AM
Aug-31-23 12:16PM
Aug-30-23 04:15PM
12:41PM
Aug-29-23 01:02PM
Aug-24-23 05:27PM
Aug-18-23 11:39AM
Aug-17-23 05:15PM
Aug-03-23 03:52PM
Jul-27-23 07:30AM
07:30AM
06:19AM
Jul-26-23 08:05PM
07:41AM
07:30AM
Jul-20-23 02:30PM
Jul-06-23 01:13PM
Jun-29-23 04:15PM
Jun-28-23 10:24AM
Jun-27-23 10:07AM
07:37AM
07:22AM
Jun-22-23 08:00AM
Jun-05-23 04:15PM
01:00PM
Jun-02-23 01:38PM
Fortive Corp. engages in the design, development, manufacturing, and marketing of professional and engineered products, software, and services for a variety of end markets. It operates through the following segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides solutions to accelerate industrial and facility reliability and performance, as well as compliance and safety across a range of vertical end markets, including manufacturing, process industries, healthcare, utilities and power, communications, and electronics. The Precision Technologies segment supplies technologies such as electrical test and measurement instruments and services, energetic material devices, and a broad portfolio of sensor and control system solutions. The Advanced Healthcare Solutions segment serves healthcare customers with products and services for critical activities, including instrument and device reprocessing, instrument tracking, cell therapy equipment design and manufacturing, biomedical test tools, radiation safety monitoring, and asset management. The company was founded by James A. Lico and Stacey A. Walker on November 10, 2015 and is headquartered in Everett, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Walker Stacey A.SVP - Human ResourcesFeb 29 '24Sale85.1184271,66335,716Mar 01 05:23 PM
Walker Stacey A.SVP - Human ResourcesFeb 28 '24Option Exercise33.362,33177,76245,664Mar 01 05:23 PM
McLaughlin Charles ESVP - Chief Financial OfficerFeb 28 '24Sale86.2840,8373,523,41661,855Mar 01 05:23 PM
Walker Stacey A.SVP - Human ResourcesFeb 28 '24Sale86.509,106787,66936,558Mar 01 05:23 PM
Underwood Peter CSVP - General CounselFeb 28 '24Sale86.395,000431,95047,138Mar 01 05:23 PM
Schwarz Jonathan LSVP - Corporate DevelopmentFeb 23 '24Option Exercise31.0711,315351,55767,116Feb 27 06:14 PM
Newcombe Tamara S.President & CEO of AHS and PTFeb 16 '24Sale85.005,000425,00055,017Feb 20 08:32 PM
Mulhall Christopher M.VP - Chief Accounting OfficerFeb 09 '24Option Exercise36.098,994324,60129,558Feb 12 06:55 PM
Mulhall Christopher M.VP - Chief Accounting OfficerFeb 09 '24Option Exercise35.616,088216,78812,072Feb 12 06:55 PM
Mulhall Christopher M.VP - Chief Accounting OfficerFeb 09 '24Sale82.178,994739,03720,564Feb 12 06:55 PM
Mulhall Christopher M.VP - Chief Accounting OfficerFeb 09 '24Sale82.266,088500,7995,984Feb 12 06:55 PM
LICO JAMES APresident and CEOFeb 06 '24Option Exercise30.61106,5253,260,982546,473Feb 06 06:40 PM
LICO JAMES APresident and CEOFeb 06 '24Sale81.50106,5258,681,347439,948Feb 06 06:40 PM
LICO JAMES APresident and CEOFeb 02 '24Option Exercise31.07100,0003,107,000539,948Feb 06 06:40 PM
LICO JAMES APresident and CEOFeb 02 '24Sale82.30100,0008,230,000439,948Feb 06 06:40 PM
LICO JAMES APresident and CEOJul 28 '23Option Exercise27.26185,5405,057,820485,797Jul 31 05:47 PM
Murphy Patrick KPresident & CEO of AHSJul 28 '23Option Exercise35.3821,793771,03682,509Jul 31 05:49 PM
McLaughlin Charles ESVP - Chief Financial OfficerJul 28 '23Option Exercise27.2616,911460,994118,230Jul 31 05:51 PM
Mulhall Christopher M.VP - Chief Accounting OfficerJul 28 '23Option Exercise29.634,436131,43610,549Jul 31 05:54 PM
Mulhall Christopher M.VP - Chief Accounting OfficerJul 28 '23Option Exercise29.323,869113,43426,207Jul 31 05:54 PM
Murphy Patrick KPresident & CEO of AHSJul 28 '23Sale76.5021,7931,667,16460,716Jul 31 05:49 PM
McLaughlin Charles ESVP - Chief Financial OfficerJul 28 '23Sale76.6616,9111,296,397101,319Jul 31 05:51 PM
Mulhall Christopher M.VP - Chief Accounting OfficerJul 28 '23Sale76.854,700361,19521,507Jul 31 05:54 PM
Mulhall Christopher M.VP - Chief Accounting OfficerJul 28 '23Sale76.844,436340,8626,113Jul 31 05:54 PM